Wecare Probiotics announced a landmark strategic partnership with Dassault Systèmes, the world leader in Product Lifecycle Management (PLM) solutions. The official signing ceremony on July 20, 2025, marks a significant milestone in Wecare' journey toward advanced digitalization and sustainable growth.

Wecare Probiotics, as a leading technological innovator, is excited to announce the significant potential of its flagship probiotic strain, Lacticaseibacillus Rhamnosus LRa05, in advancing women's health.

July 10, 2025 – In light of World Allergy Day and the recent World Allergy Week 2025, which highlighted the critical theme of Anaphylaxis, Wecare Probiotics would like to share insights from an ongoing clinical trial (NCT06699537) involving its flagship probiotic strain, Lacticasibacillus Rhamnosus LRa05.

Wecare Probiotics' Bifidobacterium animalis subsp. lactis BLa80 has achieved historic triple recognition

Wecare Probiotics, a leading innovator in the probiotic industry, today proudly announced that its advanced Bifidobacterium lactis strain, BLa80, has been officially included in China's national whitelist of probiotic strains approved for use in infant and young children's food.

The global sleep aids market is experiencing robust growth, driven by increasing consumer awareness of sleep health and the rising prevalence of sleep disorders such as insomnia and sleep apnea.